← Eichor
Condition: Cystic Fibrosis Pulmonary Exacerbation Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cystic Fibrosis Pulmonary Exacerbation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · 6 location(s) · Alexander Horsley · NCT07484607Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
NA · 33 location(s) · University of Washington, the Collaborative Health Studies C · NCT06654752e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
NA · 1 location(s) · University of Valencia · NCT06313827Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Phase 4 · 60 location(s) · Chris Goss · NCT05548283Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)
Phase N/A · 1 location(s) · Fondation Ildys · NCT07629986Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT06546943Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchie
Phase N/A · 1 location(s) · Papworth Hospital NHS Foundation Trust · NCT07289100Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
Phase N/A · 18 location(s) · Alexander Horsley · NCT06940531
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.